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Abstract
Purpose of review—Non-invasive neuroimaging methods have been developed as powerful 
tools for identifying in vivo brain functions for studies in humans and animals. Here we review the 
imaging biomarkers that are being used to determine the changes within brain metabolic and 
vascular functions induced by caloric restriction (CR), and their potential usefulness for future 
studies with dietary interventions in humans.
Recent findings—CR causes an early shift in brain metabolism of glucose to ketone bodies, and 
enhances ATP production, neuronal activity and cerebral blood flow (CBF). With age, CR 
preserves mitochondrial activity, neurotransmission, CBF, and spatial memory. CR also reduces 
anxiety in aging mice. Neuroimaging studies in humans show that CR restores abnormal brain 
activity in the amygdala of women with obesity and enhances brain connectivity in old adults.
Summary—Neuroimaging methods have excellent translational values and can be widely applied 
in future studies to identify dietary effects on brain functions in humans.
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Introduction
Brain metabolic and vascular integrity plays an important role in determining cognitive 
capability and mental health. Failure to maintain cerebral metabolic rate of glucose 
(CMRglc) has been shown to lead to cognitive impairment and brain volume atrophy, as 
observed in normal aging and in patients with diabetes and Alzheimer’s disease (AD) [1]. 
Similarly, studies have shown that neurovascular risk is highly associated with accelerated 
decline in language ability, verbal memory, attention and visuospatial abilities [2, 3]. 
Reduced cerebral blood flow (CBF) is linked to anxiety and depression [4–6], and impaired 
blood-brain barrier is associated with neuroinflammation and synaptic dysfunction [7]. 
These metabolic and hemodynamic reductions precede brain structural alteration (gray 
matter and white matter atrophy) and cognitive impairment [8–10]. Therefore, preserving 
brain metabolism (i.e., glucose oxidative capacity) and hemodynamics are critical for 
optimizing our lifespan and healthspan [11].
Caloric restriction (CR), without malnutrition, has been repeatedly shown to extend life 
expectancy as well as enhance brain functions [12–15]. On biochemical and molecular level, 
CR shows to improve glucose homeostasis and insulin sensitivity [16, 17], up-regulate brain-
derived neuro-trophic factor [18–20], and reduce oxidative stress and inflammation [21–24]. 
CR also shows beneficial effects on vascular system by decreasing blood pressure, 
atherogenic lipids, inflammatory cytokines and increased cellular stress resistance [25, 26]. 
In line with this, animals treated with CR had lower incidences of age-related 
neurodegenerative disorders and diabetes [27, 28]. However, experiments on biochemical 
and molecular levels may limit CR research to animal models, in conditions of in vitro or ex 
vivo, and their findings might not be fully translated to humans.
Noninvasive neuroimaging methods have been developed as powerful tools for identifying in 
vivo metabolic and vascular biomarkers, including positron emission tomography (PET), 
and magnetic resonance imaging (MRI) and spectroscopy (MRS) [29, 30]. Among these, 
PET with fluorine-18 (18F)-labeled 2-fluoro-2-deoxy-d-glucose (18FDG) tracer and proton 
(1H) MRS are the well-established methods to quantify CMRglc and neural metabolites, 
respectively. Other novel techniques, including 1H[13C] proton-observed-carbon-edited 
(POCE) NMR, have also developed to determine brain bioenergetics in aging brain. MRI-
based arterial spin labeling (ASL) uses arterial blood water as an endogenous tracer to 
determine quantitative cerebral blood flow (CBF), which refers to the rate of delivery of 
arterial blood to the capillary bed in brain tissue and is quantified in milliliters of blood per 
100 g of brain tissue per minute. Table 1 summarizes the imaging techniques. These imaging 
methods have been widely used in humans, and have been “reversely” translated to be used 
animal studies. Using these advanced imaging techniques, we are able to identify the CR-
induced changes in brain metabolic and vascular functions over time in studies related to 
aging and neurodegenerative diseases. Here we review the imaging biomarkers being used to 
determine the CR effects on brain metabolic and vascular functions, and their potential 
usefulness for future studies with dietary interventions in humans.
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Neuroimaging Evidence of Preserving Brain Metabolic Functions by CR
Mitochondria are the powerhouse of the cells. Mitochondrial oxidative phosphorylation of 
glucose is the predominate mode of energy generation in mammalian species. CR effects 
have been extensively studied in isolated mitochondria, showing increased capacity for 
oxidative phosphorylation resulting from elevated mitochondrial respiration or increased 
mitochondrial biogenesis. Mammalian brain has the highest energy demand of any organ 
based on its size; mitochondrial function plays a critical role in supporting neuronal activity 
and functional processes of the brain.
Using advanced POCE techniques, we are able to trace in vivo mitochondrial activity [31]. 
With the infusion of 13C- labeled glucose, the mitochondrial glucose oxidation rates in 
neurons can be measured (CMRglc(ox),N; μmol/g/min). The POCE techniques also provide 
information for glutamate–glutamine neurotransmitter cycling (Vcycle; μmol/g/min), which 
allows us to determine neuronal activity at the same time. We have recently reported the of 
measure CMRglc(ox),N and Vcycle in aged rats chronically treated with CR diet (24 months of 
age). We compared the results from young ad libitum (AL; 5 months of age) and age-
matched old AL (i.e., healthy aging) rats. We found that, compared with the young AL, 
neuronal energy production and neurotransmission rates were significantly reduced in 
healthy aging. However, old CR rats had similar levels of CMRglc(ox),N and Vcycle compared 
to those of young AL rats, suggesting preserved mitochondrial functions and neuronal 
activity (Fig. 1A). We calculated adenosine triphosphate (ATP) production rate for the three 
groups, and found that old CR rats also had comparable outcomes with the young AL.
1H MRS is another in vivo imaging technique, which permits visualization of various 
markers for cellular integrity and function (Fig. 1B). In a recent study, we used 1H-MRS to 
determine energy metabolites in hippocampus in young and old mice fed with either AL or 
40% CR diet [32]. We found that young CR mice had significant increases of total creatine 
(TCr), a high-energy substrate, compared to young AL mice. Although TCr dropped 
dramatically when the CR mice were getting old, the level was still comparable to the young 
AL, and higher than that of the old AL. TCr is the sum of creatine and phosphorus creatine 
(plays a crucial role as an intracellular buffer during the production of ATP), suggesting that 
CR increases ATP production in young CR mice, and preserves ATP production in old CR 
mice. We also found significantly elevated Taurine in young CR compared to the young AL 
mice. As Taurine is associated with neurotransmitter modulation, this may indicate that 
young CR mice have an early enhancement of neuronal activity compared to the age-
matched AL mice. Collectively, data from POCE and 1H-MRS indicate that CR enhances 
brain metabolism and neuronal activity at early stage, and preserves these functions in aging.
As glucose is the predominate energy substrate for sustaining mitochondrial functions and 
neuronal activity, we further investigated the CR effects on brain glucose uptake 
using 18FDG-PET. Based on the findings with POCE and 1H-MRS, we expected that brain 
glucose uptake would also be enhanced at early stage and preserved with age. To our 
surprise, CR dramatically reduces brain glucose uptake in young mice, both globally and in 
the regions related to cognitive functions (e.g., hippocampus and frontal cortex) (Fig. 1C, 
left). In addition, the similar lower level of glucose uptake was maintained with age [32]. 
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Similar results were also found in rats; old CR rats had significantly lower glucose uptake in 
the various brain regions compared to that of the age-matched AL rats [33]. These CMRglc 
changes are in line with the evidence of down-regulation mammalian target of rapamycin 
(mTOR) signaling by CR. mTOR is a nutrient sensor, a serine/threonine protein that is 
expressed at high levels in the brain. It serves as a potent neuronal survival and division 
signal, responding to different signals, such as nutrients, growth factors, and stress [34].
The PET imaging findings led us to speculate that brain may use alternative fuel subtracts to 
sustain mitochondrial activity and neuronal functions. In addition to glucose, brain uses 
ketone bodies as energy source [35]. We thus used mass spectroscopy to measure the levels 
of ketone bodies, beta-hydroxylbutyrate (BHB) from the brain tissue. We found that old rats 
(24months of age) with CR diet had significantly increased BHB level, compared with the 
age-matched and young (5 months of age) AL rats. Similarly, young and old CR mice had 
significantly higher ketone bodies in the blood compared to their age-matched AL mice [32]. 
Our findings suggested that CR induces a metabolic shift from glucose to ketone bodies 
utilization in the brain at very early stage.
Increased ketone bodies metabolism suggest increased oxidative metabolism. Utilization of 
ketone bodies significantly elevates the oxygen utilization in mitochondria through beta-
oxidation of fatty acid [36, 37]. This is supported by evidence from isolated mitochondria, 
showing CR enhances mitochondrial function and induces bioenergetic efficiency [38]. This 
is also consistent with our previous imaging findings that old animals with chronic CR diet 
had preserved oxidative metabolism, mitochondrial functions (TCA cycle flux and ATP 
production), and neuronal activity (neurotransmission rate) compared to the old AL animals 
[31]. The increased oxidative metabolism, particularly in brain regions associated with 
cognition (e.g., frontal cortex and hippocampus), may also play a crucial role for neuronal 
and cognitive protections.
Previous studies showed that cognition-associated brain regions have non-oxidative 
glycolysis exceeding the required needs of oxidative phosphorylation, a phenomenon known 
as aerobic glycolysis (AG) [39]. Excessive AG (or the “Warburg effect”) is a key process 
that sustains T cell activation and differentiation, and involved in inflammatory-mediated 
conditions [40]. In line with this, the distribution of AG in normal young adults is spatially 
correlated with Aβ deposition in AD patients and cognitively normal individuals with 
elevated Aβ [41, 42]. Animal studies further demonstrated that Aβ plaque formation is an 
activity dependent process associated with AG [41, 43]. Therefore, increased oxidative 
metabolism in cognition-related regions may decrease AG and thus reduce the risk for AD, 
consistent with the findings in CR mice [44, 45]. Reduced AD risk was also found in rhesus 
monkeys, showing CR impedes age-related iron deposition in the brain, which consequently 
reduces the potential interaction between metal and Aβ, and thus decelerates the 
pathogenesis of AD [46, 47].
Taken together, using multi-modal imaging methods we can demonstrate that CR enhances 
oxidative metabolism at early stage and decelerates the decline with age; the preservation of 
brain oxidative metabolism may be contributed by the shifted utilization from glucose to 
ketone bodies.
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Neuroimaging Evidence of Preserving Brain Vascular Functions by CR
CBF is highly correlated with local neuronal activity and metabolism, known as 
neurovascular coupling. Neurovascular coupling is used as a surrogate marker of brain 
function [48, 49]. In light of the metabolic preservation by CR, we further investigated CBF 
in rodents fed with AL and 40% CR diet. We found that CR significantly enhanced CBF 
when mice were young (Fig. 1C, right) and decelerated the rate of CBF decline in aging 
[50]. As a result, old CR mice (20–24 months of age) had similar levels of CBF compared to 
the young AL mice, indicating CBF preservation in aging. Similar results were found in rats, 
showing that old rats with chronic CR diet had much higher CBF compared to the age-
matched animal, and had comparable CBF level compared to the young AL rats [33]. These 
findings indicate that CR had early enhancement on CBF and is preserved with age, which is 
consistent with the metabolic results.
We further identified the potential mechanism of the CR-induced changes on CBF. We 
previously showed that mTOR inhibited activated endothelial nitric oxide synthase (eNOS) 
and releases vasodilator nitric oxide, which results in increased CBF [51, 52]. To determine 
whether the enhancement of CBF in young adult mice is also associated with mTOR 
signaling, we measured the protein levels of mTOR and eNOS in capillaries isolated from 
young CR and AL mice. We found that, CR mice had significantly lower levels of mTOR 
compared to AL mice but higher level of eNOS, consistent with our previous findings [51]. 
In addition, mTOR-induced changes in metabolism (e.g., shift from glucose to ketone bodies 
metabolism) are also associated with CBF changes. Two studies show that an acute increase 
in ketone bodies concentration via infusion of BHB, increased CBF without affecting the 
overall cerebral metabolic activity; suggesting that ketone bodies have direct effect on the 
cerebral endothelium to increase CBF, independent of metabolic interactions [53, 54]. In 
addition, ketogenesis is also associated with downregulated mTOR activity [55] and 
upregulated adenosine monophosphate-activated protein kinase [56]. Both of these changes 
can activate endothelial nitric oxide synthase signaling and consequently increase CBF [57].
It has been shown that lifelong CR was able to mitigate the age-related endothelial 
dysfunction in conduit arteries and partially in cerebral resistance arteries. CR has been 
demonstrated to exert beneficial effects in the cerebromicrovascular endothelial cells of 
young and aged rats fed with CR diet compared to the control group, demonstrating that CR 
could help prevent endothelial dysfunction and alleviate the decrease in CBF that comes 
with age [58]. This is also consistent with the literature in that CR preserves vascular 
functions and vascular density in aging [59, 60].
Correlation of Neuroimaging outcomes with Cognition and Anxiety
CR has been repeatedly shown to improve memory in aging, both for studies in humans and 
animals [61–64]. We had similar observations in a recent study, showing CR had 
significantly protective effects on learning and spatial memory for old mice in a Radial Arm 
Water Maze task [50]. The cognitive outcomes are correlated with CBF in hippocampus and 
frontal cortex, the brain areas regulating learning and memory. The findings indicate that 
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level of CBF in cognition-associated brain regions may play a critical role for determining 
performances on learning and spatial memory.
In the same study, we used elevated plus maze (EPM) to evaluate anxiety of the mice. The 
EPM consists of two open and two closed arms. Mice with higher anxiety had the tendency 
to stay in the closed arms because closed arms are perceived as safe zones. We determined 
the anxiety-related behavior by measuring the time spent in the closed arms over the 5 min 
test session. For the young mice, we did not find significant differences between the CR and 
AL groups, though CR mice had a trend of less time in the closed arms. In contrast, old AL 
mice spent significantly longer time in the closed arms compared to the old CR mice, 
indicating higher anxiety of the old AL mice. Consequently, when comparing the age-related 
performances, the AL group showed higher increases in anxiety (31.43% group averaged) 
compared to the CR mice (12.54% group averaged). Our findings are consistent with those 
in middle-aged rhesus monkeys, showing CR potentially alters their reaction to stressful 
situations. The enhanced resilience to stress in the monkeys has been linked to preserved 
brain volume and density in the emotional-control core and endocrine axis [65].
We further identified that anxiety level in the mice had significant and inverse correlations 
with CBF in hippocampus and in frontal cortex [50]. These findings indicate that 
preservation of CBF with age is pivotal for sustaining memory and mental health. More 
importantly, this positive impact on cognitive functions may also be attributed to early-life 
changes in neurovascular and neurometabolic functions. A recent study suggested that 
neuroprotective mechanisms play a major role during early stages and compensatory 
mechanisms in later stages of neurological diseases [66]. This is consistent with our imaging 
findings that CR induces early enhancements, and later preservation, on brain metabolic and 
vascular physiology.
Neuroimaging Biomarkers for Human Aging and CR Interventions
The non-invasive metabolic and vascular imaging methods have been extensively applied in 
humans for studies related to normal cerebral physiology [49, 67], aging, and 
neurodegenerative disorders [29, 30]. Consistent with what we found in the animal models, 
metabolic and vascular functions decline were also observed in human aging brain.
Cross-sectional 18FDG-PET studies have repeatedly shown that brain glucose metabolism 
decreases with age in frontal cortex, anterior cingulate cortex, ventral and dorsal lateral 
prefrontal/inferior frontal cortex, medial prefrontal areas and precentral and perisylvian 
areas [68–70]. These regional changes are paralleled by global CMRglc reductions of 
approximately 6% per decade [71]. Interestingly, this rate of CMRglc decrease is consistent 
with decreased brain structural integrity and the estimated rate of decrease in synaptic 
density measured postmortem in healthy elderly brains [72, 73]. Reduced synaptic density is 
associated with cognitive impairment [74]. In line with this, longitudinal 18FDG-PET studies 
that monitored changes in cognitive performance in healthy aging subjects showed that 
CMRglc changes in the parieto-temporal cortex correlate with cognitive decline over time. 
Studies show that CMRglc in memory and learning-related brain regions among normal 
aging subjects, including hippocampus and entorhinal cortex, accurately predict future 
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decline from normal cognition to mild cognitive impairment (MCI) and AD [75, 76]. With a 
6–14 years of follow-up scans, the rate of hippocampal CMRglc reduction in healthy elderly 
individuals was less than 1% per year, whereas patients who decline to MCI and AD had 
significantly higher rates of CMRglc reductions of 2.4–4.4% per year, respectively.
Using combined infusions of [1-13C] glucose and [2-13C] acetate with POCE, Boumezbeur 
et al. identified the difference of in vivo mitochondrial function between a healthy group of 
elderly subjects and a group of young adult controls [77]. They found that, compared with 
young subjects, neuronal mitochondrial metabolism (TCA cycle) and glutamate/glutamine 
cycle flux was 24–28% lower in elderly subjects. The reduction in individual subjects 
correlated strongly with reductions in NAA (a neuronal biomarker) and glutamate 
concentrations consistent with chronic reductions in brain mitochondrial function. In 
contrast, in the elderly, glial mitochondrial metabolism increased 30% compared with that of 
young subjects, indicating age-related changes in glial mitochondrial metabolism [78].
The decline of brain glucose metabolism in aging brain needs ketone bodies (KB) as an 
alternative fuel substrates to sustain brain functions. However, unlike in the condition of CR, 
the aging brain does not have sufficient KB production or storage to cope with the 
bioenergetics deficits. Instead, it uses catabolism of myelin lipids to generate KB as an 
adaptive response to address brain fuel and energy demand [79]. This is consistent with 
findings that white matter degeneration is as a pathological hallmark in aging and 
neurodegenerative disorders; and an increase in fatty acids and mitochondrial fatty acid 
metabolism machinery is coincident with a rise in brain ketone bodies and decline in plasma 
ketone bodies. This mechanistic pathway links mitochondrial dysfunction early in aging 
with later age development of white matter degeneration [80].
Neurovascular functions also decline with age. CBF of the cerebral cortex and the basal 
forebrain correlated significantly with advancing age [81]. Vascular pathological burden as 
hypoperfusion and neurodegeneration both precede and parallel cognitive decline [82]. In 
the elderly without dementia but with memory dysfunction, cerebral circulatory and vascular 
abnormalities have been suggested to contribute to MCI and AD [83]. The neurovascular 
risk is highly associated with accelerated decline in executive functions and cognition, 
including language, verbal memory, attention and visuospatial abilities [2, 3]. Mental health, 
such as anxiety and depression, is also link to reduced CBF [4–6], similar to our 
observations in animal models [50].
Neuroimaging studies indicate that rodents and humans have similar patterns for vascular 
and metabolic changes in brain aging. As we have seen neuroprotective effects of CR in 
rodents, we expect that effects would also be seen in humans. However, quantitative 
metabolic and vascular measurements induced by CR using neuroimaging have not been 
reported in human studies. Instead, functional MRI (fMRI), a qualitative determination, has 
been applied in humans for CR-related studies (Table 1). fMRI is a functional neuroimaging 
procedure using MRI technology that measures brain activity by detecting changes 
associated with CBF, with an assumption that CBF and brain activity are tightly coupled [84, 
85].
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Using fMRI and structural measurements, Witte et al. reported potential effects on memory 
performance in older adults using resveratrol supplement, a promising CR-mimetic nutrient 
[86]. Before and after the intervention/control period, they let the participants undergo 
memory tasks and neuroimaging to assess volume, microstructure, and functional 
connectivity (FC) of the hippocampus, a key region implicated in memory functions. They 
also assayed their anthropometry, glucose, lipid metabolism, inflammation, neurotrophic 
factors, and vascular parameters. They observed a significant effect of resveratrol on word 
retention for words over 30 min period compared with placebo. In addition, resveratrol led 
to significant increases in hippocampal FC and leptin levels, and decreases in glycated 
hemoglobin (HbA1c) and body fat compared with placebo. Increases in FC between the left 
posterior hippocampus and the medial prefrontal cortex correlated with increases in 
retention scores and with decreases in HbA1c. This study provides initial evidence that 
supplementary resveratrol improves memory performance in association with improved 
glucose metabolism and increased hippocampal FC in older adults.
In another study, using fMRI, Jakobsdottir et al. reported that CR can reverse abnormal brain 
activity in brain areas (e.g., amygdala) involved in processing visual food related stimuli of 
postmenopausal women with obesity [87]. They observed that before weight loss, increased 
activation of the right amygdala was seen in response to food stimuli, and free fatty acids 
and glucose levels correlated with activity in various areas involved in food reward 
processing. In the first week of CR, obese postmenopausal women had various metabolic 
changes occur before clinically relevant weight loss was achieved. After weight loss, fasting 
ghrelin and sated leptin levels correlated with activity in these areas. Activity in the 
amygdala region and correlations with metabolic factors differ substantially before and after 
weight loss.
Collectively, the fMRI studies in humans indicate that CR may have profound impact on 
brain activity and functional connectivity in the context of brain aging and obesity. However, 
whether CR has protective effects on brain metabolic and vascular functions as we saw in 
animal models remain unknown. In the future, it would be important to use quantitative 
neuroimaging methods (e.g., 18FDG-PET, POCE, 1H-MRS, and ASL) to determine the 
metabolic and vascular changes induced by CR, and monitor effects over time, in humans.
Conclusion
CR has shown to have various effects in protecting brain functionality, including slowing 
down brain aging and reducing risks for neurodegenerative disorders. Using multi-modal, 
non-invasive neuroimaging methods, the beneficial effects of CR on brain metabolic and 
vascular functions can be detected in vivo. In this review, we discuss the imaging evidence 
of early enhancement and later preservation of metabolic and vascular functions induced by 
CR, as well as correlation between CBF and improved cognitive functions and reduced 
anxiety in animal models. As the quantitative neuroimaging methods used in animal models 
can also be used in human studies, they will have tremendous usefulness in future studies to 
identify CR and other dietary effects on brain metabolism and vasculature in humans. 
Understanding nutritional effects on brain function may have profound implications in 
human aging and age-related neurodegenerative disorders.
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Figure 1. 
(A) The POCE results showing the correlation between mitochondrial activity in neurons 
(CMRglc(ox),N) and the glutamate-glutamine neurotransmission rate (Vcycle). Old rats treated 
with CR (Old-CR; 24 months of age) showed levels of CMRglc(ox),N and Vcycle comparable 
to those of the Young-AL (6 months of age). In contrast, Old-AL had significantly lower 
CMRglc(ox),N and Vcycle. Published data from [31]. (B) A representative 1H-MRS spectrum, 
showing choline (Cho), total creatine (TCr), taurine (Tau), glutamate-glutamine complex 
(Glx), myo-inositol (mI), N-acetylaspartate (NAA), in parts per million (ppm). Published 
data from [32]. (C) (left) CMRglc visual maps from PET 18FDG imaging, showing young 
CR mice had significant lower CMRglc compared to the young AL mice; (right) CBF visual 
maps from MRI-ASL imaging, showing young CR mice had significant higher CBF 
compared to the young AL mice. The color code indicates the CMRglc and CBF in a linear 
scale. Published data from [32, 50]. (See description of each imaging method in Table 1).
Lin et al. Page 13
Curr Nutr Rep. Author manuscript; available in PMC 2018 March 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Lin et al. Page 14
Table 1
List of discussed neuroimaging methods
Imaging methods Measurements Quantitative vs. Qualitative
18FDG- PET Glucose metabolism (CMRglc)
Quantitative
POCE Mitochondrial function; Neurotransmission rate; neuronal and glial activities
1H-MRS A variety of essential brain metabolites
ASL Cerebral blood flow (CBF)
fMRI Neuronal activity in relation to CBF and blood oxygenation Qualitative
18 FDG: fluorine-18 (18F)-labeled 2-fluoro-2-deoxy-d-glucose; PET: positron emission tomography; POCE: 1H[13C] proton-observed-carbon-
edited NMR; 1H-MRS: proton magnetic resonance spectroscopy; ASL: arterial spin labeling; fMRI: functional magnetic resonance imaging
Curr Nutr Rep. Author manuscript; available in PMC 2018 March 01.
